The pleasing business trend in the first two months of 2006 justifies our optimism.
The proposed takeover of Schering is in line with our strategic objective to further grow our health care business, especially in the area of pharmaceutical specialty products.
We are optimistic about 2006. We expect a good start to the year and we think that it's possible to get GDP growth of 1.3 percent or 1.4 percent. It depends on the oil price. We have to be cautious.
We are convinced that merging the two companies will create a health care heavyweight of international standing with a strong market position based on an innovative product portfolio and a well-stocked pipeline.
If these are suitable for us and create value, we will decide whether to enter a bidding process.
Fiscal 2005 was a very good year for Bayer and we would like our stockholders to participate appropriately in our success.
We are targeting a new earnings record in 2006.
We got off to a dynamic start in 2006, continuing the previous year's positive trend in terms of both sales and earnings.
Our strategic realignment towards innovation and growth has brought a sustained improvement in the Bayer group's earning power.
Copyright © 2024 Electric Goat Media. All Rights Reserved.